Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 1/20 | 0.31 |
| ▸ | FABP4 | P15090 | 1/20 | 0.31 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9063441 | 0.77 | ACE2 (0.34) | — | |
| SCHEMBL11554595 | 0.75 | SMN1; SMN2 (0.31) | — | |
| SCHEMBL22013194 | 0.72 | AOC1 (0.32) | — | |
| SCHEMBL216708 | 0.72 | TRPV4 (0.38) | — | |
| SCHEMBL30010765 | 0.72 | TRPV4 (0.38) | — | |
| SCHEMBL3250855 | 0.71 | GABRA1 (0.30) | — | |
| SCHEMBL28186285 | 0.71 | ACE2 (0.44) | — | |
| SCHEMBL1292825 | 0.71 | GABRA1 (0.41) | — | |
| SCHEMBL3249692 | 0.70 | ACE2 (0.31) | — | |
| SCHEMBL840511 | 0.69 | ACE2 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10806746-B2 | Di- and tri-cationic glycosylated antitumor ether lipids, L-gucosylated gaels and rhamnose-linked gaels as cytotoxic agents against epithelial cancer cells and cancer stem cells | THE UNIV OF MANITOBA (CA) | 2020-10-20 | — | — | US | disclosed |
| US-20170189438-A1 | DI- and Tri-Cationic Glycosylated Antitumor Ether Lipids, L-Gucosylated Gaels and Rhamnose-Linked Gaels as Cytotoxic Agents Against Epithelial Cancer Cells and Cancer Stem Cells | THE UNIV OF MANITOBA (CA) | 2017-07-06 | — | — | US | disclosed |
| WO-2015179983-A1 | DI- AND TRI-CATIONIC GLYCOSYLATED ANTITUMOR ETHER LIPIDS, L-GUCOSYLATED GAELS AND RHAMNOSE-LINKED GAELS AS CYTOTOXIC AGENTS AGAINST EPITHELIAL CANCER CELLS AND CANCER STEM CELLS | THE UNIVERSITY OF MANITOBA (CA) | 2015-12-03 | — | — | WO | disclosed |
| US-9169283-B2 | Post-synthetic modification of nucleic acids by inverse diels-alder reaction | DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) | 2015-10-27 | — | — | US | disclosed |
| US-20130085271-A1 | POST-SYNTHETIC MODIFICATION OF NUCLEIC ACIDS BY INVERSE DIELS-ALDER REACTION | DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) | 2013-04-04 | — | — | US | disclosed |
| EP-2531514-A2 | POST-SYNTHETIC MODIFICATION OF NUCLEIC ACIDS BY INVERSE DIELS-ALDER REACTION | Deutsches Krebsforschungszentrum (DE) | 2012-12-12 | — | — | EP | disclosed |
| EP-2360167-A1 | Post-synthetic modification of nucleic acids by inverse Diels-Alder reaction | Deutsches Krebsforschungszentrum (DE) | 2011-08-24 | — | — | EP | disclosed |
| WO-2011095336-A2 | POST-SYNTHETIC MODIFICATION OF NUCLEIC ACIDS BY INVERSE DIELS-ALDER REACTION | DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) | 2011-08-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130085271-A1 | POST-SYNTHETIC MODIFICATION OF NUCLEIC ACIDS BY INVERSE DIELS-ALDER REACTION | DERA, ADAR, POLRMT | FABP3 3553/4885FABP4 3043/4885FABP5 3109/4885 |
| US-20170189438-A1 | DI- and Tri-Cationic Glycosylated Antitumor Ether Lipids, L-Gucosylated Gaels and Rhamnose-Linked Gaels as Cytotoxic Agents Against Epithelial Cancer Cells and Cancer Stem Cells | UGCG, PNLIP, B3GAT3 | FABP3 893/4885FABP4 288/4885FABP5 1596/4885 |
| US-10806746-B2 | Di- and tri-cationic glycosylated antitumor ether lipids, L-gucosylated gaels and rhamnose-linked gaels as cytotoxic agents against epithelial cancer cells and cancer stem cells | PNLIP, UGCG, LIPC | FABP3 816/4885FABP4 223/4885FABP5 1613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.